+
Open data
-
Basic information
Entry | ![]() | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Title | Lymphostatin - conformation III - pH 8 focussed on N-term | |||||||||||||||
![]() | ||||||||||||||||
![]() |
| |||||||||||||||
![]() | Virulence Factor Lymphostatin LifA Conformation III / TOXIN | |||||||||||||||
Function / homology | ![]() | |||||||||||||||
Biological species | ![]() ![]() | |||||||||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.4 Å | |||||||||||||||
![]() | Bottcher B / Schneider R / Griessmann M / Ramussen T | |||||||||||||||
Funding support | ![]()
| |||||||||||||||
![]() | ![]() Title: Structure of lymphostatin, a large multi-functional virulence factor of pathogenic Escherichia coli. Authors: Matthias Griessmann / Tim Rasmussen / Vanessa J Flegler / Christian Kraft / Ronja Schneider / Max Hateley / Lukas Spantzel / Mark P Stevens / Michael Börsch / Bettina Böttcher / ![]() ![]() Abstract: Lymphostatin is a key virulence factor of enteropathogenic and enterohaemorrhagic Escherichia coli, playing roles in bacterial colonisation of the gut and in the inhibition of lymphocyte ...Lymphostatin is a key virulence factor of enteropathogenic and enterohaemorrhagic Escherichia coli, playing roles in bacterial colonisation of the gut and in the inhibition of lymphocyte proliferation and proinflammatory responses. The protein's glycosyltransferase and cysteine protease motifs are required for activity against lymphocytes, but high-resolution structural information has proven elusive. Here, we describe the structure of lymphostatin from enteropathogenic E. coli O127:H6, determined by electron cryo-microscopy at different pH values. We observe three conformations of a highly complex molecule with two glycosyltransferase domains, one PaToxP-like protease domain, an ADP-ribosyltransferase domain, a vertex domain and a delivery domain. Long linkers hold these domains together and occlude the catalytic sites of the N-terminal glycosyltransferase and protease domains. Lymphostatin binds to bovine T-lymphocytes and HEK-293T cells, forming clusters at the plasma membrane that are internalized. With six distinct domains, lymphostatin can be regarded as a multitool of pathogenic Escherichia coli, enabling complex interactions with host cells. | |||||||||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 25.1 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 20.5 KB 20.5 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 6.9 KB | Display | ![]() |
Images | ![]() | 109 KB | ||
Masks | ![]() | 27 MB | ![]() | |
Filedesc metadata | ![]() | 7.4 KB | ||
Others | ![]() ![]() | 20.7 MB 20.7 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Validation report
Summary document | ![]() | 987.9 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 987.5 KB | Display | |
Data in XML | ![]() | 12.3 KB | Display | |
Data in CIF | ![]() | 17.2 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 9euvC ![]() 9euwC ![]() 9qb8C ![]() 9qbbC ![]() 9qhhC C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.946 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Mask #1
File | ![]() | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #1
File | emd_52994_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #2
File | emd_52994_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : Lymphostatin
Entire | Name: Lymphostatin |
---|---|
Components |
|
-Supramolecule #1: Lymphostatin
Supramolecule | Name: Lymphostatin / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
---|---|
Source (natural) | Organism: ![]() ![]() |
Molecular weight | Theoretical: 366 KDa |
-Macromolecule #1: Lymphostatin
Macromolecule | Name: Lymphostatin / type: protein_or_peptide / ID: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() ![]() |
Recombinant expression | Organism: ![]() ![]() |
Sequence | String: MRLPEKVLFP PVTSGLSGQE KQKKPKSITG FQENYQRNIR PIKTASEARL RFFDKMVSKE NSLEDVVSLG EMIQKEIYGH EQRTFSPVHH TGNWKSSLLH NALLGLANVY NGLRETEYPN TFNRDGIKST NSFRDNLLTK TRTPRDNFEE GIKHPEHATI PYDNDNESNK ...String: MRLPEKVLFP PVTSGLSGQE KQKKPKSITG FQENYQRNIR PIKTASEARL RFFDKMVSKE NSLEDVVSLG EMIQKEIYGH EQRTFSPVHH TGNWKSSLLH NALLGLANVY NGLRETEYPN TFNRDGIKST NSFRDNLLTK TRTPRDNFEE GIKHPEHATI PYDNDNESNK LLKAGKIAGN NNELLMEIKK ESQSDHQIPL SDKFLKRKKR SPVAEDKVQN SLTPENFVQK ISLSDELKTK YANEIIEIKR IMGEYNLLPD KNSRNGLKLL QKQADLLKII MEDTSVTENT FKNIEIAITD IKREYYSHTV DIEKNIHAIW VAGSPPESIS DYIKTFLKTY KEFTYYLWVD EKAFGAAKFT SVLKQIAFDL ACRTIQQNTP QKNIDFINLY NEIRKKYNNN PSGQQEYLNK LRELYATYQK ISTPLKHMFN SFFLENMIKL QDNFFNYCIV KGVTEINDEL RINYLKNVIK LSDDDIGNYQ KTINDNKDRV KKLILDLQKQ FGENRISIKD VNSLTSLSKS ENNHNYQTEM LLRWNYPAAS DLLRMYILKE HGGIYTDTDM MPAYSKQVIF KIMMQTNGDN RFLEDLKLRR AISDGVLRYV NNQNIDEVNY NEISDADKNI IKKILTEISK MPEDSIFTKI NTRIPRDTMP ILRRYHLWPD GWNIRGLNGF MLSHKGSEVI DAVIAGQNQA YRELRRIRDN IHSEIYFKQT DELSSLPDTD KIGGILVKKY LSGSLFSKFR QDTIIPEALS TLQISGPDLI QRKMLQFFRS RGVLGEEFIN ERKLSDKAYI GVYKTTGTGK YDWLTPESIG VNDVTPADES TWCIGKGRCV DDFLFKDVST LKTENLPELF LTKIDTDTFF SQWSTKTKKD LQKKIQDLTV RYNELIDSST IDFKNLYEID QMLHMIMLEM NDDIAKRSLF SLQVQISEKI RRMTIPVDNI INIYPDLHKK NDNDLSMSIK GFLASNPHTK INILYSNKTE HNIFIKDLFS FAVMENELRD IINNMSKDKT PENWEGRVML QRYLELKMKD HLSLQSSQEA NEFLEISTFI YENDFLREKI EAVKNKMNSH ELYFEKIKKE QNTWQDLSTK EQKLQLIKAL KEISGNTEKD SHYDRLLDAF FKKHNENIHN KIQRIKDEFK EYSRVAIHNI DKVIFKGQTL DRLYHEGYVF SDINTLSRYT LHGLGITGVH TEENLLPAPS SSLINILKEH YNEDEISAKL PLAYDYILNK KESSSIPVEI LNKLSELPPH ELLTPVLGQS VNPLGMGYSS DNGKITEQVI VSGADGFDNP ISGLIYTYLE DLYNIHVRMR EGTLNSQNLR QLLENSVSSC FLTEQSINKL LSEAEKRPYQ SLTEIHQHLT GLPTIADATL SLLSVGLPGT GKLLRREQDY GRPPVTAIQD STFVLPYNFK GIGFNDNIIS SAPVASSLHF IAEHAKYTLL SWPEFYRHHA QRWFEMAKGY GSQNIDFHPQ SLLVTQEGRC MGLALLYLQT EDTAHYSILQ ENLMTVSALH QTSNRDKLPL SKDDNSLMTR TYSLIEMLQY QGNKYITNES LLHKTAWNQE RITLLFNEKG VKRALISTPN HTLVLQQLED IYRLTDPNFG HADFLSPIDA LKFIEAMIQL TPTLQEYYGL LNKDINKHIQ VHYAESDMVW NKLLPENDAG LSTRIQHTTT DRLANLAEPV AVAGISLPVK TLYDIGATLD GRRITSPPTS EQIPSLRLNG DVLNDYLSRT VLTPEQADNI RKILHTQGIR SGTRPIDPEM IRGTQDDLVS SQTRLQRQAT RVKQQLAGVL DTLQQHFQNI PRSSGRHLSV ENIELADIGS GRFNLQIRDG ETLHTTSVEV PEVVSRFQKL STMLSALPAS GIMDFDLGMS VVGVVQYARL LQQGHEDSTL AKINLAMDIK QLSEATLGSM IQIAGNKFLN TEGIQGFRLE SAVAEGMRSV ATRTGGTMGK ALSASARVLE LPVLETVLGT WNLYNSVIQL QQATSYSETM AARVQIAFDS ISLGLTAASV AFPPLIIATG PIAAIGMGAS SIARNVARKE ERHTQWLEYK KFLTDGSKHI VVASPERGLL DFSGNKVFGK MVLDLRQSPP LLHGESSFNA DRKIGHRPDL GDWQIREKVG YANSISPYSS LAHGYANSKW PRTIPKIPSG EYDTIILGYG HQYQANTEIE YLSNWIVWRE AVPDSTSRHK RPPLEVLNSQ CTVIAGERKT TVLPLRVLSD LTPECTEQAI SLKDYKFILR GGSGGLAVQV GGAGYYDIDA NLVAKENTLS FRGLPEEFPL TFDLSKQTQS VMLKTPDDEV PVMTITQKGI NTLVGTAAGK DRLIGNDKDN TFHTSSGGGT VISGGGNNRY IIPRDLKTPL TLTLSSNSVS HEIFLPETTL AELKPVAFEL SLIYWAGNNI NVQPEDEAKL NHFAGNFRVH TRDGMTLEAV SRENGIQLAI SLCDVQRWQA VYPEENNRPD AILDRLHDMG WSLTPEVRFQ GGETQVSYDP LTRQLVYQLQ ARYSEFQLAG SRHHTTAVTG TPGSRYIIMK PVTTQILPTQ IILAGDNDHP ETIDLLEASP VLVEGKKDKN SVILTIATIQ YSLQLTISGI EESLPETTRV AIQPQDTRLL GDVLRILPDN GNWVGIFRSG HTPTVNRLEN LMALNQVMTF LPRVSGSAEQ VLCLENLGGV RKKVEGELLS GKLKGAWKAE GEPTVPVNIS DLSIPPYSRL YLIFEGKNNV LLRSKVHAAP LKITSAGEMQ LSERQWQQQE HIIVKPDNEA PSLILSEFRR FTISSDKTFS LKLMCHQGMV RIDRRSLSVR LFYLREQPGI GSLRLTFRDF FTEVMDTTDR EILEKELRPI LIGDTHRFIN AAYKNHLNIQ LGDGVLNLAD IVAEYARIQK EETSKILYQY QGAMKKKTDG PSVVEDAIMT TTVTTDSGEL FPTFHPWYTD DLSGRYKSVP MARKADTLYH LTPKGDLQII YQVATKMVNQ AMIVSLPNYR HEWEKYNLSI LSEIPQNNNT VVHSILRVNG PTMQVRTIDY RGTDENNPIV SFSDTTFING EQMLSYDSHS SGRVYSREEY MMWELQQRVS EASSARTQDY WLMDAAVRNG EWKITPELLR HTPGYIRSTV SKWSRGWLKT GTILQTPEDR NTDVYLTTIQ NNVFSRQGGG YQVYYRIDGM AGADIADNAP GETRCTLRPG TCFEVTSVDE RHYEWNIIYV TLKTCGWSRN GQSKTPNGDN LFN UniProtKB: Lymphostatin |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 1.25 mg/mL |
---|---|
Buffer | pH: 8 |
Vitrification | Cryogen name: ETHANE / Chamber humidity: 95 % / Chamber temperature: 277 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
Microscope | TFS KRIOS |
---|---|
Specialist optics | Energy filter - Name: TFS Selectris / Energy filter - Slit width: 5 eV |
Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Digitization - Dimensions - Width: 4096 pixel / Digitization - Dimensions - Height: 4096 pixel / Number grids imaged: 3 / Number real images: 70899 / Average exposure time: 9.9 sec. / Average electron dose: 70.0 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | C2 aperture diameter: 70.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 1.5 µm / Nominal defocus min: 0.5 µm / Nominal magnification: 130000 |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
Initial model | PDB ID: Chain - Source name: PDB / Chain - Initial model type: experimental model |
---|---|
Refinement | Protocol: RIGID BODY FIT |